Celsius Holdings (NasdaqCM:CELH) Increases Authorized Shares From 300M To 400M

Celsius Holdings (NasdaqCM:CELH) recently approved an amendment to its Articles of Incorporation, increasing its authorized Common Stock from 300 million to 400 million shares, a decision that aligns with the company's growth strategies. Over the last quarter, the company's stock price increased by 34%, possibly reflecting investor enthusiasm regarding this increased flexibility. Despite a challenging first quarter with declining earnings and net income, the company's stock price surge came amidst a broader market trend where major indices like the S&P 500 posted gains. These developments potentially added positive momentum to Celsius's share performance.

We've identified 1 possible red flag for Celsius Holdings that you should be aware of.

The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

The recent amendment increasing Celsius Holdings' authorized Common Stock aligns with its strategy for growth and operational flexibility. This decision could enhance the company's ability to fund expansion initiatives, including international ventures and partnerships. The longer-term performance of Celsius Holdings has been impressive, with a total return of over 1000% over a period of five years. This significant gain highlights robust shareholder returns driven by strategic expansions and product offerings. However, over the past year, Celsius underperformed compared to the US beverage industry, which registered a return of 3.9%, while the US market returned 11.5%.

In terms of potential impacts on future revenue and earnings forecasts, the increased share authorization may support further acquisitions and market entry efforts, potentially accelerating revenue growth. Analysts project annual revenue growth of 28.5% over the next three years. The appointment of Eric Hanson could improve operational efficiency and partnerships, which may positively affect earnings and margins. However, the company's Q1 revenue decline and increased expenses pose some risks to achieving these outcomes. Despite these factors, the company's current share price of US$35.52 is at a 15.8% discount to the consensus price target of US$42.16, reflecting mixed sentiment among analysts regarding its valuation.

Assess Celsius Holdings' previous results with our detailed historical performance reports.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com